# Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

> **NCT02583399** · PHASE4 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 30 (actual)

## Conditions studied

- Pain
- Fever

## Interventions

- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT02583399
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-08
- **Primary completion:** 2019-07-02
- **Final completion:** 2019-07-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583399, "Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02583399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*